NCT00083278 - Study of MDX-010 in Stage IV Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

February 28, 2006

Conditions

Breast CancerAdenocarcinoma

Interventions

DRUG

MDX-010

Trial Locations (14)

LaGrange, La Grange

Norton Healthcare Inc, Loiusville Oncology Clinical Research Program, Louisville

Suburban Medical Plaza II, Louisville

Audubon Oncology/Hematology, Louisville

Indiana University, Clarian Health Partners, Indianapolis

Medical Arts Building, Jeffersonville

Kansas City Oncology and Hematology Group, Lee's Summit

Kansas City Oncology and Hematology Group, Kansas City

Kansas City Oncology and Hematology Group, Kansas City

Kansas City Oncology and Hematology Group, Overland Park

Arlington Cancer Center, Arlington

Sharp Clinical Oncology Research, San Diego

Wishard Health Services, Indianapolis

Section of Hematology/Oncology, Indiana Cancer Pavilion, Indianapolis